ClinicalTrials.govpublic full text
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
acute myeloid leukemia, in relapse, myelodysplastic syndromes, chronic myeloid leukemia, myeloproliferative neoplasm, post-transplantation cyclophosphamide; post-transplantation bendamustine; acute myeloid leukemia; myelodysplastic syndrome; refractory; sorafenib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912727
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.